Evidence map›Paper›PMID 26953328›Full record

ArticleInfection and immunity2016

Identification and Characterization of the Rhoptry Neck Protein 2 in Babesia divergens and B. microti.

Rosalynn L Ord, Marilis Rodriguez, Jeny R Cursino-Santos, Hyunryung Hong, Manpreet Singh, Jeremy Gray, Cheryl A Lobo

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.9field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Advances inPathogens (Basel, Switzerland) · 2023
    Review
  5. Article
  6. Frontiers in immunology · 2020
    Article
  7. RON2, a novel gene inParasitology · 2019
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Molecular Cloning and Characterization ofJournal of parasitology research · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Rosalynn L OrdDepartment of Blood-Borne Parasites, New York Blood Center, New York, New York, USA.
Marilis RodriguezDepartment of Blood-Borne Parasites, New York Blood Center, New York, New York, USA.
Jeny R Cursino-SantosDepartment of Blood-Borne Parasites, New York Blood Center, New York, New York, USA.
Hyunryung HongDepartment of Blood-Borne Parasites, New York Blood Center, New York, New York, USA.
Manpreet SinghDepartment of Blood-Borne Parasites, New York Blood Center, New York, New York, USA.
Jeremy GrayUniversity College Dublin, School of Biology and Environmental Science, Dublin, Republic of Ireland.
Cheryl A LoboDepartment of Blood-Borne Parasites, New York Blood Center, New York, New York, USA clobo@nybloodcenter.org.
New York Blood Center · USUniversity College Dublin · IE

Funding

Babesiosis: An Emerging Infectious Threat to Transfusion MedicineR01HL105694 · NHLBI · NEW YORK BLOOD CENTER · PI LOBO, CHERYL ANN · 2011 to 2015
$2.0M
Continuous in vitro culture of Babesia microtiR21HL129215 · NHLBI · NEW YORK BLOOD CENTER · PI LOBO, CHERYL ANN · 2015 to 2016
$471k
NHLBI NIH HHS R01 HL105694NHLBI NIH HHS R21 HL129215
6 · The paper itself

Abstract

Apicomplexan parasites include those of the genera Plasmodium, Cryptosporidium, and Toxoplasma and those of the relatively understudied zoonotic genus Babesia In humans, babesiosis, particularly transfusion-transmitted babesiosis, has been emerging as a major threat to public health. Like malaria, the disease pathology is a consequence of the parasitemia which develops through cyclical replication of Babesia parasites in host erythrocytes. However, there are no exoerythrocytic stages in Babesia, so targeting of the blood stage and associated proteins to directly prevent parasite invasion is the most desirable option for effective disease control. Especially promising among such molecules are the rhoptry neck proteins (RONs), whose homologs have been identified in many apicomplexan parasites. RONs are involved in the formation of the moving junction, along with AMA1, but no RON has been identified and characterized in any Babesia spp. Here we identify the RON2 proteins of Babesia divergens (BdRON2) and B. microti (BmRON2) and show that they are localized apically and that anti-BdRON2 antibodies are significant inhibitors of parasite invasion in vitro Neither protein is immunodominant, as both proteins react only marginally with sera from infected animals. Further characterization of the direct role of both BdRON2 and BmRON2 in parasite invasion is required, but knowledge of the level of conformity of RON2 proteins within the apicomplexan phylum, particularly that of the AMA1-RON2 complex at the moving junction, along with the availability of an animal model for B. microti studies, provides a key to target this complex with a goal of preventing the erythrocytic invasion of these parasites and to further our understanding of the role of these conserved ligands in invasion.

Indexed as

EndocytosisAnimalsAntibodies, ProtozoanBabesiaErythrocytesHumansProtozoan ProteinsVirulence FactorsAntibodies, ProtozoanProtozoan ProteinsVirulence Factors

Identifiers

PMID26953328
PMCPMC4862700
OpenAlexW2372716259

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.